Frazier Lifesciences Acquisition Corp (FLAC)
$9.87
$0.18
(1.82%)
As on 22-Nov-2022 15:58EDT
Market cap
$175 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
65.8
P/B Ratio
1.4
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-10 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-34.4
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
14,301,000
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Frazier Lifesciences Acquisition Corp (FLAC)
| 1.2 | -1.4 | -0.6 | 0.5 | -- | -- | -- |
|
BSE Sensex*
| -8.9 | 2.3 | 6.1 | -5.8 | 7.0 | 8.1 | 11.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Frazier Lifesciences Acquisition Corp (FLAC)
|
9.9 | 175.2 | 0.0 | -3.6 | -- | -- | 65.8 | 1.4 |
| 10.0 | 293.5 | 0.0 | -17.2 | -- | -- | -- | 4.2 |
Shareholding Pattern
View DetailsAbout Frazier Lifesciences Acquisition Corp (FLAC)
Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in... the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington. Read more
-
CEO & Chairman
Dr. James N. Topper M.D., Ph.D.
-
CEO & Chairman
Dr. James N. Topper M.D., Ph.D.
-
Headquarters
Seattle, WA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Frazier Lifesciences Acquisition Corp (FLAC)
What is the current share price of Frazier Lifesciences Acquisition Corp (FLAC) Today?
The share price of Frazier Lifesciences Acquisition Corp (FLAC) is $9.87 (NASDAQ) as of 22-Nov-2022 15:58 EDT. Frazier Lifesciences Acquisition Corp (FLAC) has given a return of 0.51% in the last 1 years.
What is the current PB & PE ratio of Frazier Lifesciences Acquisition Corp (FLAC)?
The P/E ratio of Frazier Lifesciences Acquisition Corp (FLAC) is 65.80 times as on 23-Nov-2022.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
What is the 52 Week High and Low of Frazier Lifesciences Acquisition Corp (FLAC)?
The 52-week high and low of Frazier Lifesciences Acquisition Corp (FLAC) are Rs -- and Rs -- as of 24-Jun-2026.
What is the market cap of Frazier Lifesciences Acquisition Corp (FLAC)?
Frazier Lifesciences Acquisition Corp (FLAC) has a market capitalisation of $ 175 Mln as on 23-Nov-2022. As per SEBI classification, it is a company.
Should I invest in Frazier Lifesciences Acquisition Corp (FLAC)?
Before investing in Frazier Lifesciences Acquisition Corp (FLAC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.